Navigation Links
Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
Date:6/26/2008

BOSTON, June 26 /PRNewswire-USNewswire/ -- Headache specialists meet today in Boston for the 50th annual meeting of the American Headache Society. Learn more about headache and face pain developments of the last 50 years -- including the top five advances in headaches -- and what researchers envision for the future.

For additional information, contact: Gina Czark at 312.558.1770, ext. 139 or gczark@pcipr.com or visit http://www.headachenews.org.

Among the topics being presented, include:

-- WHY PAIN BECOMES CHRONIC: Research shows previously unknown role certain

brain cells play in triggering chronic headaches for 9 million Americans

Think that pain medication is helping you ease the throbbing of a

headache? Think again. Researchers discovered neurons are not the only

carrier of pain signals to the brain. Glial cells, which outnumber

neurons 20:1, have been shown to prompt chronic pain in a variety of

ways, such as by a virus, nerve damage or even medication. Morphine and

other opiates also activate glial cells, which mean those drugs

you're taking to alleviate pain might actually be making it worse.

-- FIRST RIGOROUS TEST OF MAGNETIC STIMULATION DEVICE SHOWS PROMISE FOR

SHORT-CIRCUITING MIGRAINES: Research shows 7 million Americans could

benefit from this treatment

Imagine simply zapping away the pain at the onset of a migraine, instead

of gulping medication and waiting for relief. Researchers are presenting

encouraging results showing a portable transcranial magnetic stimulation

device would help an estimated 39 percent of migraine sufferers. The

device, about the size and weight of a hairdryer, works by placing it to

the back of the head and pushing a button twice, sending a very brief

magnetic field pulse into the brain. The 16-site multicenter,

randomized, double blind study is the first rigorous test of the

magnetic stimulation device.

-- STIMULATING THERAPY THAT HITS A NERVE: Early Research Shows New

Implanted Device Helps Alleviate Near-Daily Migraines

Stimulating a nerve might be just the ticket to help relieve the pain of

chronic migraine sufferers. Occipital nerve stimulation, in which an

implanted neurostimulator sends electrical impulses to the central

nervous system, has been shown to help 40 percent of near-daily migraine

sufferers who don't have success with standard pain medication.

Stimulating the occipital nerve, which ignites a tingling sensation,

appears to activate mechanisms that block the perception of pain in the

brain.


'/>"/>
SOURCE American Headache Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
2. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
3. Pharmacokinetic Data Suggest NGX426, TorreyPines Therapeutics Oral Prodrug of Tezampanel, May be Effective in Treating Acute Migraine Headache
4. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial
7. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
8. Leading Immunologists Convene in Boston
9. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
10. Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientifics SpyGlass(R) Direct Visualization System
11. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... 2016  Consumers have taken a more active ... more emphasis on patient outcomes. ... the pharmaceutical industry have evolved beyond just providing ... are focusing on becoming more patient-oriented across their ... services that improve health. ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
Breaking Medicine News(10 mins):